ask="6.05"
ask_size="100"
average_daily_volume="168866"
bid="N/A"
bid_size="N/A"
book_value="3.30"
change="-0.15"
change_from_200_day_moving_average="-4.27"
change_from_50_day_moving_average="0.25"
change_from_52_week_high="-11.95"
change_From_52_week_low="1.25"
change_in_percent="-2.54%"
close="5.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.55"
ebitda="-19.50M"
eps_estimate_current_year="-2.83"
eps_estimate_next_quarter="-0.90"
eps_estimate_next_year="-2.85"
ex_dividend_date="N/A"
float_shares="5820000"
high="6.05"
high_52_weeks="17.70"
last_trade_date="2/7/2017"
last_trade_price="5.75"
last_trade_size="2017"
last_trade_time="4:00pm"
low="5.65"
low_52_weeks="4.50"
market_capitalization="44.95M"
moving_average_200_day="10.02"
moving_average_50_day="5.50"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.92"
open="5.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-42.60%"
percent_change_from_50_day_moving_average="+4.52%"
percent_change_from_52_week_high="-67.51%"
percent_change_from_52_week_low="+27.78%"
previous_close="5.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.79"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="2.40"
stock_exchange="NCM"
symbol="TRIL"
volume="93541"
weeks_range_52="4.50 - 17.70"
